Greg Walters (Excision Medical)

Overview

Greg Walters is a prominent figure in the medical device industry, known primarily for his role as the co-founder, President, and CEO of Excision Medical, Inc. Excision Medical is a startup focused on developing solutions for the management of aortic stenosis, particularly through innovative leaflet modification technology. Founded in 2020, the company aims to transform the market with its Leaflet Excision System, designed to enhance the efficacy and safety of transcatheter aortic valve replacement (TAVR) procedures. Before establishing Excision Medical, Walters had a distinguished career with technical leadership roles at several companies, including a significant tenure at Essential Medical, Inc. He is credited with several innovations and holds numerous patents in the field of medical devices.

Recent Developments

October 2024: Excision Medical completed a funding round, securing $10.9M to advance its medical technologies, marking a significant step towards expanding its product offerings and enhancing its market presence.
September 2022: Excision Medical raised $2.5M primarily to develop its Leaflet Excision System further, a critical technology for aortic stenosis management. This funding also facilitated the addition of renowned experts such as Dr. James McCabe and Dr. Adam Greenbaum to its Scientific Advisory Board.
2023-2024: Greg Walters participated as a speaker at various medical technology conferences, such as the Med-Tech World Europe Summit held in Valletta, Malta, in August 2023, showcasing Excision Medical's capability and innovation in the medical device industry.

Personal Information

Attribute	Information
Full Name	Greg Walters
Born	N/A
Nationality	American
Occupation	President/CEO of Excision Medical
Known For	Medical device innovation, Excision Medical
Net Worth	N/A
Education	BS in Physics (Millersville University of Pennsylvania), Masters of Management (Pennsylvania State University)

Early Life and Education

Greg Walters' early years set a strong foundation for his career in the medical field. Though specific details about his childhood remain limited, his academic background reflects a robust commitment to engineering and management. Walters graduated with a Bachelor of Science in Physics from Millersville University of Pennsylvania and later pursued a Master's degree in Management from Pennsylvania State University. His entry into the professional sphere began with General Electric, where he contributed as an Electro-Optics Engineer, participating in advanced engineering programs.

Career and Notable Achievements

Greg Walters' professional journey is marked by his significant contributions to medical technology:

General Electric: Started his career in engineering, developing laser technologies.
Kensey Nash Corporation: Advanced in product development, focusing on embolic protection devices and thrombectomy catheters.
Essential Medical, Inc.: Served as CEO, leading the development of groundbreaking medical devices like Angio-Seal.
Excision Medical, Inc.: Founded in 2020, aiming to innovate TAVR procedures with the Leaflet Excision System.

Current Work and Impact

As CEO of Excision Medical, Greg Walters is at the forefront of advancing solutions for aortic stenosis, a prevalent heart condition. The company’s Leaflet Excision System represents a pioneering step in the management of this condition, offering an innovative approach to TAVR procedures. Under Walters' leadership, Excision Medical's technologies promise to improve patient outcomes by reducing procedural risks and enhancing the longevity and effectiveness of valve replacements.

Conclusion

Greg Walters' work in the medical device sector highlights the critical impact of innovation on patient care and surgical outcomes. Through his leadership at Excision Medical, Walters is poised to transform TAVR procedures, providing safer and more effective treatment options. His contributions continue to inspire advancements in medical technology, with a legacy that may extend well into the future, influencing how heart diseases are managed globally.